Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Laser-captured microglia in the Alzheimer's and Parkinson's brain reveal unique regional expression profiles and suggest a potential role for hepatitis B in the Alzheimer's brain.

Mastroeni D, Nolz J, Sekar S, Delvaux E, Serrano G, Cuyugan L, Liang WS, Beach TG, Rogers J, Coleman PD.

Neurobiol Aging. 2018 Mar;63:12-21. doi: 10.1016/j.neurobiolaging.2017.10.019. Epub 2017 Nov 1.

PMID:
29207277
2.

Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?

Rogers J, Mastroeni D, Leonard B, Joyce J, Grover A.

Int Rev Neurobiol. 2007;82:235-46. Review.

PMID:
17678964
3.

Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients.

Doorn KJ, Goudriaan A, Blits-Huizinga C, Bol JG, Rozemuller AJ, Hoogland PV, Lucassen PJ, Drukarch B, van de Berg WD, van Dam AM.

Brain Pathol. 2014 Mar;24(2):152-65. doi: 10.1111/bpa.12088. Epub 2013 Oct 28.

PMID:
24033473
4.

Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease.

Pey P, Pearce RK, Kalaitzakis ME, Griffin WS, Gentleman SM.

Acta Neuropathol Commun. 2014 Feb 14;2:21. doi: 10.1186/2051-5960-2-21.

5.

Herpesviruses in brains in Alzheimer's and Parkinson's diseases.

Hemling N, Röyttä M, Rinne J, Pöllänen P, Broberg E, Tapio V, Vahlberg T, Hukkanen V.

Ann Neurol. 2003 Aug;54(2):267-71.

PMID:
12891684
6.

Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia.

Fan Z, Aman Y, Ahmed I, Chetelat G, Landeau B, Ray Chaudhuri K, Brooks DJ, Edison P.

Alzheimers Dement. 2015 Jun;11(6):608-21.e7. doi: 10.1016/j.jalz.2014.06.016. Epub 2014 Sep 16.

PMID:
25239737
7.

ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity.

Mastroeni D, Sekar S, Nolz J, Delvaux E, Lunnon K, Mill J, Liang WS, Coleman PD.

PLoS One. 2017 Jul 12;12(7):e0177814. doi: 10.1371/journal.pone.0177814. eCollection 2017. Erratum in: PLoS One. 2018 Jan 11;13(1):e0191382.

8.

A pathological study of the association between Lewy body disease and Alzheimer's disease.

Gibb WR, Mountjoy CQ, Mann DM, Lees AJ.

J Neurol Neurosurg Psychiatry. 1989 Jun;52(6):701-8.

9.

Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?

Femminella GD, Ninan S, Atkinson R, Fan Z, Brooks DJ, Edison P.

J Alzheimers Dis. 2016;51(4):1275-89. doi: 10.3233/JAD-150827.

PMID:
27060942
10.

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains.

McGeer PL, Itagaki S, Boyes BE, McGeer EG.

Neurology. 1988 Aug;38(8):1285-91.

PMID:
3399080
11.

Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson's and Alzheimer's disease.

Gellhaar S, Sunnemark D, Eriksson H, Olson L, Galter D.

Cell Tissue Res. 2017 Sep;369(3):445-454. doi: 10.1007/s00441-017-2626-8. Epub 2017 May 2.

12.

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.

Weintraub D, Dietz N, Duda JE, Wolk DA, Doshi J, Xie SX, Davatzikos C, Clark CM, Siderowf A.

Brain. 2012 Jan;135(Pt 1):170-80. doi: 10.1093/brain/awr277. Epub 2011 Nov 21.

13.

Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease.

Ginsberg SD, Alldred MJ, Che S.

Neurobiol Dis. 2012 Jan;45(1):99-107. doi: 10.1016/j.nbd.2011.07.013. Epub 2011 Jul 28.

14.

Upregulation of histone deacetylase 2 in laser capture nigral microglia in Parkinson's disease.

Tan Y, Delvaux E, Nolz J, Coleman PD, Chen S, Mastroeni D.

Neurobiol Aging. 2018 Aug;68:134-141. doi: 10.1016/j.neurobiolaging.2018.02.018. Epub 2018 Apr 3.

PMID:
29803514
15.

Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease.

Blalock EM, Buechel HM, Popovic J, Geddes JW, Landfield PW.

J Chem Neuroanat. 2011 Oct;42(2):118-26. doi: 10.1016/j.jchemneu.2011.06.007. Epub 2011 Jul 2.

16.

Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation.

Walker DG, Dalsing-Hernandez JE, Campbell NA, Lue LF.

Exp Neurol. 2009 Jan;215(1):5-19. doi: 10.1016/j.expneurol.2008.09.003. Epub 2008 Sep 24.

17.

Immunohistochemistry using antibodies to alpha-interferon and its induced protein, MxA, in Alzheimer's and Parkinson's disease brain tissues.

Yamada T, Horisberger MA, Kawaguchi N, Moroo I, Toyoda T.

Neurosci Lett. 1994 Nov 7;181(1-2):61-4.

PMID:
7898772
18.

Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.

Streit WJ, Braak H, Xue QS, Bechmann I.

Acta Neuropathol. 2009 Oct;118(4):475-85. doi: 10.1007/s00401-009-0556-6. Epub 2009 Jun 10.

19.

Neuropathological substrates of Alzheimer's disease and Parkinson's disease.

Jellinger K.

J Neural Transm Suppl. 1987;24:109-29. Review.

PMID:
3316494
20.

Supplemental Content

Support Center